-
-
Small Molecule Drug Platform
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Flow-through cell
显示更多 -
-
Peptide Platform
显示更多 -
Research Team
显示更多
-
![](/npublic/img/s.png)
Service Platform
Related Services and Solutions
![We look forward to working with you and providing you with excellent service. We look forward to working with you and providing you with excellent service.](/npublic/img/s.png)
We look forward to working with you and providing you with excellent service.
DP Production Base — Siwei Pharma
Siwei Pharma supports end-to-end DP R&D and production from preclinical development, registration batch manufacturing, to commercial production.
![](https://omo-oss-image.thefastimg.com/portal-saas/new2023050917060170378/cms/image/a0407714-b810-4771-b5ec-c8d1fe26b7e8.jpg)
Floor area:Approx. 120,000 m2
Quality management:We plan to build five solid dosage form workshops and two injection workshops that meet Chinese, US, and EU regulatory standards.
Dosage forms:We plan to produce a wide range of dosage forms, including solid and liquid dosage forms and powders for injection.
Production Equipment
Business Collaboration
Innovative Drug CDMO Services
![Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://omo-oss-image.thefastimg.com/portal-saas/new2023050917060170378/cms/image/af9820f2-7496-4bb9-a939-cbf57718f448.jpg)